PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 901 (118th)

Disposable ENDS Product Enforcement Act of 2023

referredUnited States· United States Congress· EN

Introduced

9 February 2023

Last action

17 February 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Sheila Cherfilus-McCormick, Raúl Grijalva, Shri Thanedar, Jonathan Jackson, Al Green, Rep. Doggett, Lloyd [D-TX-37], Jill Tokuda, Rep. Crockett, Jasmine [D-TX-30], Gwen Moore, Rep. Williams, Nikema [D-GA-5], Jesús García, Sheila Jackson Lee, Rep. Carter, Troy A. [D-LA-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Lieu, Ted [D-CA-36], Rep. Davis, Danny K. [D-IL-7], Rep. Costa, Jim [D-CA-21], Colin Allred, Rep. Sewell, Terri A. [D-AL-7], Barbara Lee, Glenn Ivey, Shontel Brown, Cory Mills, Vicente Gonzalez

Subjects

Healthcare

Source updated

24 July 2024

Healthcare

Official sourceDownload fileView documentsShare

Summary

Disposable ENDS Product Enforcement Act of 2023 This bill requires the Food and Drug Administration (FDA) to update its enforcement guidance regarding Electronic Nicotine Delivery System (ENDS) products to include certain disposable ENDS products. In April 2020, the FDA published revised guidance on how it intends to prioritize enforcement resources with respect to ENDS products that do not have premarket authorization (i.e., that have not received FDA approval). The guidance specifies that the FDA intends to prioritize enforcement against (1) flavored, cartridge-based ENDS products (except for tobacco or menthol flavored products); (2) other ENDS products for which the manufacturer has not taken adequate measures to prevent access to minors; (3) any ENDS products that are targeted or promoted towards minors; and (4) any ENDS products for which the manufacturer has not submitted an application for market approval or did not receive approval. For purposes of this guidance, cartridge-based ENDS products do not include disposable products that are completely self-contained . The bill requires the FDA to incorporate these products, including nicotine products that are not derived from tobacco, into its enforcement priorities. The bill additionally specifies that the FDA may prioritize enforcement against these products in advance of updating the guidance. The FDA must also annually report on its enforcement actions with respect to these products.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 9 February 2023

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 9 February 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 9 February 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 17 February 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.